Executive Summary Parkinson’s Disorder Drugs Market: Share, Size & Strategic Insights
CAGR Value
The global Parkinson’s disorder drugs market size was valued at USD 5.19 billion in 2024 and is expected to reach USD 13.70 billion by 2032, at a CAGR of 12.90% during the forecast period
For an excellent outcome of Parkinson’s Disorder...
The Future of CNS Therapeutics: Innovation, AI, and Personalized Medicine
CNS Therapeutics Market Overview 2025–2033
The Global Central Nervous System (CNS) Therapeutics Market is undergoing a significant transformation as neuroscience, biotechnology, and digital innovation converge to address complex neurological and psychiatric disorders. Valued at USD 123.7 billion...
Moving Beyond Symptomatic Relief: The Rise of Disease-Modifying Agents
What is the core shift in the Parkinson’s therapeutic landscape?
The historical cornerstone of the Parkinson’s Disease Therapeutics Market has been symptomatic relief, primarily through levodopa-based therapies. However, we are now entering an era where the focus is shifting toward disease-modifying therapies...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek